On May 9, 2019 top researchers and practitioners of military medicine will come together to honor the 2019 Heroes of Military Medicine.

HJF prides itself on being careful stewards of the resources it uses, especially those celebrated on Earth Day!

HJF, along with Uniformed Services University were awarded up to $24.5 million to advance treatments for two lethal henipaviruses.

HJF has teamed with Tracy's Kids to help provide pediatric art therapy to cancer patients at a military treatment facility

Developing Vaccines and Therapies for the Highly Pathogenic Nipah and Hendra Viruses with HJF and multiple partners.

Tom Weston, SVP and CFO of ECS Federal, LLC. has joined HJF's Council of Directors.

HJF has entered into a cooperative agreement with the Defense POW/MIA Accounting Agency.

HJF has selected Uniformed Services University doctoral student to receive a fellowship for the 2018-19 academic year.

HJF has facilitated the transfer of the m102.4 antibody, an experimental therapy for Nipah virus infection, from Queensland, Australia to Kerala, India.

HJF President and CEO Joseph Caravalho, Jr., M.D., recently served as a panelist during the “Science and Synergy” Spring Research Summit.

HJF has announced a license agreement of the vaccine for Nipah virus and Hendra virus.

Physicians are not burning out, but struggling with “moral injury,” according to Wendy Dean, M.D., senior medical officer and Simon Talbot, M.D..

The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) held its 8 annual Heroes of Military Medicine Awards on May 3.

This public-private research initiative, launched in April 2015 follows a cohort of veterans over the years of their transition from military to civilian life.

<p>NPR covered research by one of HJF's researchers examining brain research.&nbsp;</p>